SEMA7A and myocardial ischemia: For instance, Sema7A promotes platelet activation in myocardial ischemia and reperfusion and simultaneously enhances leukocyte extravasation, suggesting Sema7A as a potential therapeutic target for the treatment of thrombo-inflammatory reperfusion injury diseases, such as acute coronary ischemic diseases and stroke.